Ads
-
Related paper
- Biochemical Markers for Alzheimer’s and Parkinson’s Disease
- Natural Products for the Therapy of Proteinopathies Underlying the Neurodegenerative Conditions: Protein Misfolding and Fibrillization in Alzheimer’s Disease and Parkinson’s Disease| Biomed Grid
- Biochemical Markers for Determining Vulnerable Atherosclerotic Plaque in Stenotic Patient: Biochemical Markers Study of Myeloperoxidase (MPO), Matrix Metallo-Proteinase-9 (MMP-9), Secretory Phospholipase A2 (SPLA2) and CD40 Ligand
- THE IMPACT OF EMOTIONS, AMBIGUITY, AND APATHY ON DECISIONMAKING IN INDIVIDUALS WITH ALZHEIMER'S DISEASE: A PROPOSAL TO FACILITATE DIAGNOSIS OF ALZHEIMER'S DISEASE
- EFFECTS OF PHYSICAL THERAPY ON THE LEVEL OF KINESIOPHOBIA, SOMATIC MARKERS OF SARCOPENIA AND INDICATORS OF FALL RISK IN ELDERLY PERSONS WITH PARKINSON'S DISEASE
- Biochemical markers for early detection of cardiovascular disease in smokers
- Perspectives for Treating Alzheimer’s Disease: A Review on Indigeous Plants for Alzheimer Disease
- To study biochemical markers in chronic obstructive pulmonary disease patients
- Biochemical Markers for Differential Diagnosis of Stroke A Biochemical Markers Study of S100B Protein, Neuron Spesific Enolase (NSE), Myelin Basic Protein (MBP), and Heart-Type Fatty Acid Binding Protein (H-FABP)
- Diseases Related to Alzheimer’s Disease and Alzheimer’s Special Care Units (Scu): Mixed Results